Residue 33 of human equilibrative nucleoside transporter 2 is a functionally important component of both the dipyridamole and nucleoside binding sites

Molecular Pharmacology

Volumn 67, Issue 4, 2005, Pages 1291-1298

  Visser, Frank ^a,b   Zhang, Jing ^a,b   Raborn, R Taylor ^a,b   Baldwin, Stephen A ^c   Young, James D ^a   Cass, Carol E ^a,b  

^a UNIVERSITY OF ALBERTA   (Canada)

^b CROSS CANCER INSTITUTE   (Canada)

^c UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE; CHLOROMERCURIBENZENESULFONIC ACID; CYSTEINE; DILAZEP; DIPYRIDAMOLE; EQUILIBRATIVE NUCLEOSIDE TRANSPORTER 1; EQUILIBRATIVE NUCLEOSIDE TRANSPORTER 2; METHIONINE; NUCLEOSIDE DERIVATIVE; PURINE NUCLEOSIDE; PYRIMIDINE NUCLEOSIDE; SERINE; SULFUR; URIDINE;

AMINO ACID SEQUENCE; ARTICLE; BINDING AFFINITY; DRUG BINDING SITE; ENERGY; ENZYME INHIBITION; ENZYME KINETICS; GENE MUTATION; HYDROGEN BOND; NONHUMAN; PRIORITY JOURNAL; WILD TYPE;

ADENOSINE; BINDING SITES; BIOLOGICAL TRANSPORT; DILAZEP; DIPYRIDAMOLE; EQUILIBRATIVE NUCLEOSIDE TRANSPORTER 1; EQUILIBRATIVE-NUCLEOSIDE TRANSPORTER 2; HUMANS; NUCLEOSIDES; STRUCTURE-ACTIVITY RELATIONSHIP; URIDINE;

EID: 15744373314     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.104.005884     Document Type: Article

References (40)

1. Abramson J, Smirnova I, Kasho V, Verner G, Kaback HR, and Iwata S (2003) Structure and mechanism of the lactose permease of Escherichia coli. Science (Wash DC) 301:610-615.
2. Acimovic Y and Coe IR (2002) Molecular evolution of the equilibrative nucleoside transporter family: identification of novel family members in prokaryotes and eukaryotes. Mol Biol Evol 19:2199-2210.
3. Arastu-Kapur S, Ford E, Ullman B, and Carter NS (2003) Functional analysis of an inosine-guanosine transporter from Leishmania donovani. The role of conserved residues, aspartate 389 and arginine 393. J Biol Chem 278:33327-33333.
4. Boleti H, Coe IR, Baldwin SA, Young JD, and Cass CE (1997) Molecular identification of the equilibrative NBMPR-sensitive (es) nucleoside transporter and demonstration of an equilibrative NBMPR-insensitive (ei) transport activity in human erythroleukemia (K562) cells. Neuropharmacology 36:1167-1179.
5. Brunelli JP and Pall ML (1993) A series of yeast/Escherichia coli λ expression vectors designed for directional cloning of cDNAs and cre/lox-mediated plasmid excision. Yeast 9:1309-1318.
6. Cass CE, Young JD, Baldwin SA, Cabrita MA, Graham KA, Griffiths M, Jennings LL, Mackey JK, Ng AML, Ritzel MWL, et al. (1999) Nucleoside transporters of mammalian cells, in Membrane Transporters as Drug Targets (Amidon GL and Sadee W eds), Kluwer Academic/Plenum Publishers. New York.
7. Cheng Y and Prusoff WH (1973) Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction. Biochem Pharmacol 22:3099-3108.
8. Crawford CR, Patel DH, Naeve C, and Belt JA (1998) Cloning of the human equilibrative, nitrobenzylmercaptopurine riboside (NBMPR)-insensitive nucleoside transporter ei by functional expression in a transport-deficient cell line. J Biol Chem 273:5288-5293.
9. Endres CJ, SenGupta DJ, and Unadkat JD (2004) Mutation of leucine 92 selectively reduces the apparent affinity of inosine, guanosine, NBMPR and dilazep for the human equilibrative nucleoside transporter, hENT1. Biochem J 380:131-137.
10. Gellman SH (1991) On the role of methionine residues in the sequence-independent recognition of nonpolar protein surfaces. Biochemistry 30:6633-6636.
11. Gietz D, St. Jean A, Woods RA, and Schiestl RH (1992) Improved method for high efficiency transformation of intact yeast cells. Nucleic Acids Res 20:1425.
12. Griffith DA and Jarvis SM (1996) Nucleoside and nucleobase transport systems of mammalian cells. Biochim Biophys Acta 1286:153-181.
13. Griffiths M, Beaumont N, Yao SY, Sundaram M, Boumah CE, Davies A, Kwong FY, Coe I, Cass CE, Young JD, et al. (1997a) Cloning of a human nucleoside transporter implicated in the cellular uptake of adenosine and chemotherapeutic drugs. Nat Med 3:89-93.
14. Griffiths M, Yao SY, Abidi F, Phillips SE, Cass CE, Young JD, and Baldwin SA (1997b) Molecular cloning and characterization of a nitrobenzylthioinosine- insensitive (ei) equilibrative nucleoside transporter from human placenta. Biochem J 328:739-743.
15. Hyde RJ, Cass CE, Young JD, and Baldwin SA (2001) The ENT family of eukaryote nucleoside and nucleobase transporters: recent advances in the investigation of structure/function relationships and the identification of novel isoforms. Mol Membr Biol 18:53-63.
16. Jarvis SM (1986) Nitrobenzylthioinosine-sensitive nucleoside transport system: mechanism of inhibition by dipyridamole. Mol Pharmacol 30:659-665.
17. Jarvis SM, Janmohamed SN, and Young JD (1983) Kinetics of nitrobenzylthioinosine binding to the human erythrocyte nucleoside transporter. Biochem J 216: 661-667.
18. Jarvis SM and Young JD (1986) Nucleoside transport in rat erythrocytes: two components with differences in sensitivity to inhibition by nitrobenzylthioinosine and p-chloromercuriphenyl sulfonate. J Membr Biol 93:1-10.
19. Koren R, Cass CE, and Paterson AR (1983) The kinetics of dissociation of the inhibitor of nucleoside transport, nitrobenzylthioinosine, from the high-affinity binding sites of cultured hamster cells. Biochem J 216:299-308.
20. Osato DH, Huang CC, Kawamoto M, Johns SJ, Stryke D, Wang J, Ferrin TE, Herskowitz I, and Giacomini KM (2003) Functional characterization in yeast of genetic variants in the human equilibrative nucleoside transporter, ENT1. Pharmacogenetics 13:297-301.
21. Pal D and Chakrabarti P (2001) Non-hydrogen bond interactions involving the methionine sulfur atom. J Biomol Struct Dyn 19:115-128.
22. Paterson AK, Lau EY, Dahlig E, and Cass CE (1980) A common basis for inhibition of nucleoside transport by dipyridamole and nitrobenzylthioinosine? Mol Pharmacol 18:40-44.
23. SenGupta DJ, Lum PY, Lai Y, Shubochkina E, Bakken AH, Schneider G, and Unadkat JD (2002) A single glycine mutation in the equilibrative nucleoside transporter gene, hENT1, alters nucleoside transport activity and sensitivity to nitrobenzylthioinosine. Biochemistry 41:1512-1519.
24. SenGupta DJ and Unadkat JD (2004) Glycine 154 of the equilibrative nucleoside transporter, hENT1, is important for nucleoside transport and for conferring sensitivity to the inhibitors nitrobenzylthioinosine, dipyridamole and dilazep. Biochem Pharmacol 67:453-458.
25. Sundaram M, Yao SY, Ingram JC, Berry ZA, Abidi F, Cass CE, Baldwin SA, and Young JD (2001a) Topology of a human equilibrative, nitrobenzylthioinosine (NBMPR)-sensitive nucleoside transporter (hENT1) implicated in the cellular uptake of adenosine and anti-cancer drugs. J Biol Chem 276:45270-45275.
26. Sundaram M, Yao SYM, Ng AML, Cass CE, Baldwin SA, and Young JD (2001b) Equilibrative nucleoside transporters. Mapping regions of interaction for the substrate analogue nitrobenzylthioinosine (NBMPR) using rat chimeric proteins. Biochemistry 40:8146-8151.
27. Sundaram M, Yao SYM, Ng AML, Griffiths M, Cass CE, Baldwin SA, and Young JD (1998) Chimeric constructs between human and rat equilibrative nucleoside transporters (hENT1 and rENT1) reveal hENT1 structural domains interacting with coronary vasoactive drugs. J Biol Chem 273:21519-21525.
28. Valdes R, Vasudevan G, Conklin D, and Landfear SM (2004) Transmembrane domain 5 of the LdNT1.1 nucleoside transporter is an amphipathic helix that forms part of the nucleoside translocation pathway. Biochemistry 43:6793-6802.
29. Van Belle H (1993) Nucleoside transport inhibition: a therapeutic approach to cardioprotection via adenosine? Cardiovasc Res 27:68-76.
30. Vasudevan G, Ullman B, and Landfear SM (2001) Point mutations in a nucleoside transporter gene from Leishmania donovani confer drug resistance and alter substrate selectivity. Proc Natl Acad Sci USA 98:6092-6097.
31. Vickers MF, Yao SY, Baldwin SA, Young JD, and Cass CE (2000) Nucleoside transporter proteins of Saccharomyces cerevisiae. Demonstration of a transporter (FUI1) with high uridine selectivity in plasma membranes and a transporter (FUN26) with broad nucleoside selectivity in intracellular membranes. J Biol Chem 275:25931-25938.
32. Vickers MF, Zhang J, Visser F, Tackaberry T, Robins MJ, Nielsen LP, Nowak I, Baldwin SA, Young JD, and Cass CE (2004) Uridine recognition motifs of human equilibrative nucleoside transporters 1 and 2 produced in Saccharomyces cerevisiae. Nucleosides Nucleotides Nucleic Acids 23:361-373.
33. Viguera AR and Serrano L (1995) Side-chain interactions between sulfur-containing amino acids and phenylalanine in alpha-helices. Biochemistry 34:8771-8779.
34. Visser F, Vickers MF, Ng AM, Baldwin SA, Young JD, and Cass CE (2002) Mutation of residue 33 of human equilibrative nucleoside transporters 1 and 2 alters sensitivity to inhibition of transport by dilazep and dipyridamole. J Biol Chem 277:395-401.
35. Ward JL, Sherali A, Mo ZP, and Tse CM (2000) Kinetic and pharmacological properties of cloned human equilibrative nucleoside transporters, ENT1 and ENT2, stably expressed in nucleoside transporter-deficient PK15 cells. Ent2 exhibits a low affinity for guanosine and cytidine but a high affinity for inosine. J Biol Chem 275:8375-8381.
36. Yao SM, Sundaram M, Chomey EG, Cass CE, Baldwin SA, and Young JD (2001a) Identification of Cys140 in helix 4 as an exofacial cysteine residue within the substrate-translocation channel of rat equilibrative nitrobenzylthioinosine (NBMPR)-insensitive nucleoside transporter rENT2. Biochem J 353:387-393.
37. Yao SY, Ng AM, Muzyka WH, Griffiths M, Cass CE, Baldwin SA, and Young JD (1997) Molecular cloning and functional characterization of nitrobenzylthioinosine (NBMPR)-sensitive (es) and NBMPR-insensitive (ei) equilibrative nucleoside transporter proteins (rENT1 and rENT2) from rat tissues. J Biol Chem 272: 28423-28430.
38. Yao SY, Ng AM, Sundaram M, Cass CE, Baldwin SA, and Young JD (2001b) Transport of antiviral 3′-deoxy-nucleoside drugs by recombinant human and rat equilibrative, nitrobenzylthioinosine (NBMPR)-insensitive (ENT2) nucleoside transporter proteins produced in Xenopus oocytes. Mol Membr Biol 18:161-167.
39. Yao SY, Ng AM, Vickers MF, Sundaram M, Cass CE, Baldwin SA, and Young JD (2002) Functional and molecular characterization of nucleobase transport by recombinant human and rat equilibrative nucleoside transporters 1 and 2. Chimeric constructs reveal a role for the ENT2 helix 5-6 region in nucleobase translocation. J Biol Chem 277:24938-24948.
40. Zhang J, Visser F, Vickers MF, Lang T, Robins MJ, Nielsen LPC, Nowak I, Baldwin SA, Young JD, and Cass CE (2003) Uridine binding motifs of human concentrative nucleoside transporters 1 and 3 (hCNT1 and hCNT3) produced in Saccharomyces cerevisiae. Mol Pharmacol 64:1512-1520.